Document Detail


Short-term developmental outcome of iron prophylaxis in infants.
MedLine Citation:
PMID:  11192518     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Previous studies on the cognitive effects of iron treatment have focused on anemic or non-anemic iron-deficient infants. The effect of iron supplementation on cognitive development among iron-sufficient infants has not been studied. The aim of the present study was to examine the effect of iron supplementation on performance in the Bayley Scales of Infant Development (BSID) and anthropometric measurement in 6-month-old iron-sufficient healthy infants. METHODS: Healthy, iron-sufficient infants who were 6 months of age and were attending the Well Baby Clinic were considered for enrollment. Infants were randomly assigned to take ferrous sulfate supplementation (1 mg/kg per day) or no supplementation and were followed for 3 months. Anthropometric measurement, hematologic status and BSID were evaluated on admission and after 3 months. RESULTS: Seven infants in the intervention group and nine in the control group completed the study. No significant differences were observed in anthropometric measurements and complete blood counts between the two groups after the 3 month study period. The mean transferrin saturation (TS) level decreased significantly in the control group during the study period (from 15.3+/-2.6 to 7.8+/-5.1%; P = 0.0117), but no such reduction was seen in the intervention group. At the end of the study, the TS of the control group was found to be significantly lower than that of the intervention group (7.8+/-5.1 vs. 19.9+/-7.9%, respectively; P = 0.0033). The BSID scores of infants in both groups were within the normal range on admission and at the end of the study period. CONCLUSIONS: Short-term iron supplementation did not change developmental test scores despite the hematologic response in iron-sufficient healthy infants. The high prevelance of iron-deficiency anemia and its relationship with adverse developmental outcome suggests that prevention of iron-deficiency anemia with prophylaxis needs to be emphasized, rather than treatment.
Authors:
S S Yalçin; K Yurdakök; D Açikgöz; E Ozmert
Related Documents :
19111318 - Iron supplementation of low-income infants: a randomized clinical trial of adherence wi...
9433148 - Absorption of iron from grape-molasses and ferrous sulfate: a comparative study in norm...
17468128 - Zinc, copper, selenium and manganese blood levels in preterm infants.
4003328 - Tea drinking and microcytic anemia in infants.
22574798 - Cost utility of palivizumab prophylaxis among pre-term infants in the united states: a ...
1905658 - Distinction between clostridium botulinum type a strains associated with food-borne bot...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Pediatrics international : official journal of the Japan Pediatric Society     Volume:  42     ISSN:  1328-8067     ISO Abbreviation:  Pediatr Int     Publication Date:  2000 Dec 
Date Detail:
Created Date:  2001-01-15     Completed Date:  2001-04-26     Revised Date:  2008-05-21    
Medline Journal Info:
Nlm Unique ID:  100886002     Medline TA:  Pediatr Int     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  625-30     Citation Subset:  IM    
Affiliation:
Department of Social Pediatrics, Institute of Child Health, Ankara, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anemia, Iron-Deficiency / prevention & control*
Child Development / drug effects*,  physiology
Cognition / drug effects
Female
Follow-Up Studies
Humans
Infant
Iron / administration & dosage,  therapeutic use*
Male
Prevalence
Reference Values
Chemical
Reg. No./Substance:
7439-89-6/Iron

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Stepwise multimodal approach in the treatment of Kasabach-Merritt syndrome.
Next Document:  Killing of human Herpes virus 6-infected cells by lymphocytes cultured with interleukin-2 or -12.